Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.
about
Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolonesFluorescence-Based Strategies to Investigate the Structure and Dynamics of Aptamer-Ligand ComplexesHIV-1 reverse transcriptionThe recognition domain of the methyl-specific endonuclease McrBC flips out 5-methylcytosineFluorescent pyrimidine ribonucleotide: synthesis, enzymatic incorporation, and utilization.Investigating local conformations of double-stranded DNA by low-energy circular dichroism of pyrrolo-cytosine.Solid-Phase Synthesis of 5'-O-β,γ-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase.Fluorescent analogs of biomolecular building blocks: design, properties, and applications.Synthesis of nucleoside 5'-O-alpha,beta-methylene-beta-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptaseReverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.RNA polymerase pausing and nascent-RNA structure formation are linked through clamp-domain movementMutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivoAlternate polypurine tracts affect rous sarcoma virus integration in vivo.Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis.Folding of the hammerhead ribozyme: pyrrolo-cytosine fluorescence separates core folding from global folding and reveals a pH-dependent conformational change.Probing Retroviral and Retrotransposon Genome Structures: The "SHAPE" of Things to Come.Synthetic nucleotides as probes of DNA polymerase specificity.Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands.Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase InhibitorsThe effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybridsDNA hairpins containing the cytidine analog pyrrolo-dC: structural, thermodynamic, and spectroscopic studies.High-resolution NMR analysis of the conformations of native and base analog substituted retroviral and LTR-retrotransposon PPT primers.An emissive C analog distinguishes between G, 8-oxoG, and T.Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavageFluorescent nucleic acid base analogues.Fluorescent DNA-based enzyme sensors.Two modes of HIV-1 polypurine tract cleavage are affected by introducing locked nucleic acid analogs into the (-) DNA template.Structural studies of RNA/DNA polypurine tracts.Functionalized tricyclic cytosine analogues provide nucleoside fluorophores with improved photophysical properties and a range of solvent sensitivities.Enzymatic incorporation of emissive pyrimidine ribonucleotides.A single-label phenylpyrrolocytidine provides a molecular beacon-like response reporting HIV-1 RT RNase H activity.Pyrrolo-C as a fluorescent probe for monitoring RNA secondary structure formation.Examining Ty3 polypurine tract structure and function by nucleoside analog interference.The 6-methoxymethyl derivative of pyrrolo-dC for selective fluorometric detection of guanosine-containing sequences.Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase.
P2860
Q24798680-74346BE9-8AB4-4186-AD1C-ADCC93860FB4Q26740493-1579ECE1-A053-43C1-A270-209C633487B5Q27023387-1318DC76-1C23-4E70-B456-4272F4F1A8F5Q27678979-26D9D793-2D5A-4666-A46A-B8ED81A723ECQ33270489-12DA3C1F-8725-447A-B6FE-6B986E31D80EQ33821647-54E20881-F0BA-4D46-87D6-B6471BB1E1EFQ33831172-0A1B0B26-2965-44CD-8420-3E4053203664Q33846993-A8DAA2D8-87A2-48F6-BF06-3E89D0CE1036Q34085799-B58157C5-FD5B-4A1B-996B-D635F79A17B1Q34092798-E85FC0E1-4E58-4F1C-A35B-08C03ED3B9C8Q34145524-C151822C-B566-442E-A26B-FC114C356F79Q34232962-94CC4D6C-6DF7-488F-8477-0E2BB460651EQ35101520-69B73817-173A-4A5A-95D6-1A51426A6545Q35646719-1812367C-861B-462B-B688-EEDAFE007855Q35775781-45637189-89BB-4099-950B-998B3C56A0B3Q35996898-12426E6E-3036-402A-9FB2-AC606F96B878Q36040168-6DC92FAB-8DFC-4923-982F-B998B47E07ECQ36649670-B5D80079-AEE2-44F8-ABF0-077A97D7DD3FQ36760555-9AC20701-EE63-415E-8D72-DCCCBB8E6A18Q36845889-20A395E5-CF66-402E-A69E-59F99EEFDDE3Q36949852-E1352DD2-3AD4-488E-8067-50474D3FA8DEQ36972129-8061A10D-D3AF-47C5-B770-F504E94577DBQ37279331-B3B52DFC-0010-42D2-83D1-D8611317E43AQ37310911-FCCFB501-3B03-481F-B95D-EF09087B5027Q37395809-8E50658C-F26F-453C-8E27-DEE5FE59F587Q37596444-CEB2CEFF-6710-45C5-ADF6-48C26A369686Q37755509-1744C511-409A-4327-A47D-B7FA56AD88AEQ37835020-491D1661-23C5-4BAB-8231-652A535F436FQ38339601-AC44E2D3-9C2F-4ADE-9873-6FBE628D5394Q39287405-30086D3B-4909-424E-A746-4CD5CBB7C767Q39604404-BF718716-5DA2-4285-A11D-1666E8CF916BQ42053767-9CE5F003-38E0-4572-8DFF-C5E294EFA52AQ42921961-015F74DD-F230-45DC-B4D4-5351902C5D33Q43226653-E0C2CF43-1D7A-47C6-A808-74B4C8B33C95Q46818299-E9393D56-F50F-47FC-942D-930B9DFC983DQ46860597-F521751B-96BD-46FE-BD27-225E94A9FE7FQ47364014-E761D138-DF20-4CFF-AAB9-9800EC85C94C
P2860
Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@en
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@nl
type
label
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@en
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@nl
prefLabel
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@en
Using pyrrolo-deoxycytosine to ...... us type-1 3' polypurine tract.
@nl
P2860
P356
P1476
Using pyrrolo-deoxycytosine to ...... rus type-1 3' polypurine tract
@en
P2093
Jason W Rausch
Stuart F J Le Grice
P2860
P304
P356
10.1093/NAR/GKH307
P407
P577
2004-03-05T00:00:00Z